Milestone Scientific Inc. (MLSS) - Pangali EV/EBITDA

Milestone Scientific (MLSS) generates revenue through the sale of advanced Wand systems designed for comfortable dental injections. A steady cash flow is driven by consistent demand for replacement parts. The company's valuation evolution reflects an EV/EBITDA ratio of 0.00. However, growth is hindered by practitioners' adherence to legacy methods, the high cost of equipment relative to simple alternatives, and challenges in securing insurance reimbursements.

The history of EV/EBITDA values for Milestone Scientific (MLSS) reflects the efficiency with which the implementation of ESG precision dosing technologies has been integrated into the business capitalization. This multiple compares the total enterprise value with its operating profit before depreciation and taxes, allowing investors to determine the real value of assets regardless of debt load and financing structure to assess investment attractiveness.